Beutels, P; Edmunds, WJ; Antonanzas, F; de Wit, GA; Evans, D; Feilden, R; Fendrick, AM; Ginsberg, GM; Glick, HA; Mast, E; +3 more... Pechevis, M; van Doorslaer, EK; van Hout, BA; (2002) Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. PharmacoEconomics, 20 (1). pp. 1-7. ISSN 1170-7690 DOI: https://doi.org/10.2165/00019053-200220010-00001 Full text not available from this repository.

Brisson, M; Edmunds, WJ; (2006) Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs. Medical decision making, 26 (5). pp. 434-46. ISSN 0272-989X DOI: https://doi.org/10.1177/0272989X06290485 Full text not available from this repository.

Carabin, H; Edmunds, WJ; Kou, U; van Den Hof, S; Nguyen, VH; (2002) The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC public health, 2. p. 22. ISSN 1471-2458 DOI: https://doi.org/10.1186/1471-2458-2-22

Gregg, M; Blackhouse, G; Loeb, M; Goeree, R; (2014) Economic evaluation of an influenza immunization strategy of healthy children. International journal of technology assessment in health care, 30 (4). pp. 394-9. ISSN 0266-4623 DOI: https://doi.org/10.1017/S0266462314000397 Full text not available from this repository.

Hall, AJ; (2003) Vaccination politics. Tropical medicine & international health, 8 (1). pp. 1-2. ISSN 1360-2276 DOI: https://doi.org/10.1046/j.1365-3156.2003.00985.x Full text not available from this repository.

Trotter, CL; Edmunds, WJ; (2002) Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ, 324 (7341). p. 809. ISSN 0959-535X DOI: https://doi.org/10.1136/bmj.324.7341.809